Graf Acquisition Corp. IV Business Finance Contracts & Agreements
82 Contracts & Agreements
- Funding Agreements (1 contract)
- Investment Agreements (1)
- Joinder Agreements (1)
- Loan Agreements (4)
- Note Agreements (14)
- Purchase Agreements (26)
- Registration Rights Agreements (5)
- Stock Agreements (6)
- Subscription Agreements (2)
- Term Sheets (1)
- Underwriting Agreements (2)
- Warrant Agreements (19)
- Seventh Amendment to Forward Purchase Agreement, dated as of December 31, 2024, among NKGen and Meteora Capital Partners, LP and certain of its affiliates (Filed With SEC on January 2, 2025)
- Convertible Promissory Note, dated December 31, 2024, issued to AlpineBrook Capital GP I Limited (Filed With SEC on January 2, 2025)
- Loan Agreement, dated December 31, 2024, by and among NKGen Biotech, Inc., NKGen Operating Biotech, Inc. and AlpineBrook Capital GP I Limited (Filed With SEC on January 2, 2025)
- Common Stock Purchase Warrant, dated December 31, 2024, issued to AlpineBrook Capital GP I Limited (Filed With SEC on January 2, 2025)
- Conditional Investment Agreement, dated November 20, 2024, by and between NKGen Biotech, Inc. and NKMAX Co., Ltd (Filed With SEC on December 2, 2024)
- Sixth Amendment to Forward Purchase Agreement, dated as of September 5, 2024, among NKGen and Meteora Capital Partners, LP and certain of its affiliates (Filed With SEC on September 11, 2024)
- Securities Purchase Agreement, dated August 7, 2024, by and between the Purchaser and the Company (Filed With SEC on August 9, 2024)
- Promissory Note issued to the Purchaser, dated August 7, 2024 (Filed With SEC on August 9, 2024)
- Common Stock Purchase Warrant issued to the Purchaser, dated August 7, 2024 (Filed With SEC on August 9, 2024)
- Amendment to Forward Purchase Agreement, dated as of July 29, 2024, among NKGen and Sandia Investment Management LP on behalf of the investors thereto (Filed With SEC on July 30, 2024)
- Amendment to Forward Purchase Agreement, dated as of July 29, 2024, among NKGen and Polar Multi-Strategy Master Fund (Filed With SEC on July 29, 2024)
- Fifth Amendment to Forward Purchase Agreement, dated as of July 12, 2024, among NKGen and Meteora Capital Partners, LP and certain of its affiliates (Filed With SEC on July 17, 2024)
- Promissory Note issued to AJB, dated June 18, 2024 (Filed With SEC on June 21, 2024)
- Common Stock Purchase Warrant issued to AJB, dated June 18, 2024 (Filed With SEC on June 21, 2024)
- First Amendment to Securities Purchase Agreement, dated as of May 13, 2024, between the Company and Alpha (Filed With SEC on May 13, 2024)
- Securities Purchase Agreement, dated May 9, 2024, by and between AJB and the Company (Filed With SEC on May 10, 2024)
- Promissory Note issued to AJB, dated May 9, 2024 (Filed With SEC on May 10, 2024)
- Securities Purchase Agreement, dated May 7, 2024, by and between Alpha and the Company (Filed With SEC on May 10, 2024)
- Promissory Note issued to Alpha, dated May 7, 2024 (Filed With SEC on May 10, 2024)
- Securities Purchase Agreement, dated May 7, 2024, by and among Meteora and the Company (Filed With SEC on May 10, 2024)
- Promissory Note issued to Meteora, dated May 7, 2024 (Filed With SEC on May 10, 2024)
- Common Stock Purchase Warrant issued to AJB, dated May 9, 2024 (Filed With SEC on May 10, 2024)
- Common Stock Purchase Warrant issued to Alpha, dated May 7, 2024 (Filed With SEC on May 10, 2024)
- Common Stock Purchase Warrant issued to Meteora, dated May 7, 2024 (Filed With SEC on May 10, 2024)
- Form of Amended and Restated Warrant (Filed With SEC on April 29, 2024)
- Second Amendment to Forward Purchase Agreement, dated as of April 18, 2024, among NKGen and Sandia Investment Management LP on behalf of the investors thereto (Filed With SEC on April 25, 2024)
- Third Amendment to the Loan Agreement, dated April 5, 2024, by and between NKGen Operating Biotech, Inc. and East West Bank (Filed With SEC on April 11, 2024)
- Registration Rights Agreement, dated April 5, 2024, by and between NKGen Biotech, Inc. and BDW Investments LLC (Filed With SEC on April 11, 2024)
- Secured Convertible Promissory Note executed by NKGen Biotech, Inc. and NKGen Operating Biotech, Inc. in favor of BDW Investments LLC, dated April 5, 2024 (Filed With SEC on April 11, 2024)
- Equity and Business Loan Agreement, dated April 5, 2024, by and among NKGen Biotech, Inc., NKGen Operating Biotech, Inc. and BDW Investments LLC (Filed With SEC on April 11, 2024)
- Common Stock Purchase Warrant issued by NKGen Biotech, Inc. in favor of BDW Investments LLC, dated April 5, 2024 (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement, dated April, 2024, by and among Sandia and the Company (Filed With SEC on April 5, 2024)
- Promissory Note issued to Sandia, dated April 1, 2024 (Filed With SEC on April 5, 2024)
- Securities Purchase Agreement, dated April 1, 2024, by and between AJB and the Company (Filed With SEC on April 5, 2024)
- Promissory Note issued to AJB, dated April 1, 2024 (Filed With SEC on April 5, 2024)
- Common Stock Purchase Warrant issued to Sandia, dated April 1, 2024 (Filed With SEC on April 5, 2024)
- Common Stock Purchase Warrant issued to AJB, dated April 1, 2024 (Filed With SEC on April 5, 2024)
- Securities Purchase Agreement, dated March 26, 2024, by and among Meteora and the Company (Filed With SEC on March 27, 2024)
- Promissory Note issued to Meteora, dated March 26, 2024 (Filed With SEC on March 27, 2024)
- Securities Purchase Agreement, dated March 21, 2024, by and between FirstFire and the Company (Filed With SEC on March 27, 2024)
